Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 143.26
0.944 %
$ 14.5 B
Market Cap
38.2
P/E
NBIX - TAX PROVISION
Tax Provision NBIX - Neurocrine Biosciences, Inc.
82.4 M
LAST VALUE
164.25%
2 YEAR CAGR
157.35%
5 YEAR CAGR
35.86%
10 YEAR CAGR